Page last updated: 2024-10-25

dantrolene and Retinal Diseases

dantrolene has been researched along with Retinal Diseases in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Retinal Diseases: Diseases involving the RETINA.

Research Excerpts

ExcerptRelevanceReference
"In this study we used two calcium antagonists which have two different modes of action, nimodipine and dantrolene, to prevent NMDA-induced retinal ischemia in guinea pigs."3.72Calcium antagonists in N-methyl d-aspartate-induced retinal injury. ( Altuntaş, I; Kaya, M; Ozdemir, T; Tunç, M, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaya, M1
Tunç, M1
Ozdemir, T1
Altuntaş, I1

Other Studies

1 other study available for dantrolene and Retinal Diseases

ArticleYear
Calcium antagonists in N-methyl d-aspartate-induced retinal injury.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2003, Volume: 241, Issue:5

    Topics: Animals; Calcium Channel Blockers; Cell Count; Dantrolene; Drug Therapy, Combination; Excitatory Ami

2003